Professor Lehmann’s research interests include the immune consequences of local and systemic inflammation (e.g., sepsis, stroke), intravital imaging of the microcirculation in animal models and clinical studies, and the development of new pharmacological approaches for inflammation and infection.

Lehmann C, Sharawi N, Al-Banna N, Corbett N, Kuethe JW, Caldwell CC. Novel approaches to the development of anti-sepsis drugs. Expert Opin Drug Discov. 2014 May;9(5):523-31 Toguri JT, Lehmann C, Laprairie RB, Szczesniak AM, Zhou J, Denovan-Wright EM, Kelly ME. Anti-inflammatory effects of Cannabinoid 2 Receptor activation in endotoxin-induced uveitis. Br J Pharmacol. 2014 Mar;171(6):1448-61 Lehmann C, Abdo I, Kern H, Maddison L, Pavlovic D, Sharawi N, Starkopf J, Hall R, Johnson P, Williams L, Cerny V. Clinical evaluation of the intestinal microcirculation using sidestream dark field imaging - Recommendations of a round table meeting. Clin Hemorheol Microcirc. 2014 Jan 1;57(2):137-46 Lehmann C, Burkovskiy I, Kuethe J, Zhou J, Caldwell C, Kelly ME. Inhibition of the cannabinoid 2 receptor in CNS-injury induced immunodeficiency syndrome. Med Hypotheses. 2014 Jun;82(6):736-9 Lehmann C, Islam S, Jarosch S, Zhou J, Hoskin D, Greenshields A, Al-Banna N, Sharawy N, Sczcesniak A, Kelly MEM, Wafa K, Cheliak W, Holbein BE: The utility of iron chelators in the management of inflammatory disorders. Mediators Inflamm 2014 (in press)